Methods and systems for monitoring, diagnosing, and treating chronic obstructive pulmonary disease

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9677138
SERIAL NO

14402607

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A novel set of 98 genes expressed in the respiratory tract epithelium that serve as biomarkers for measuring chronic obstructive pulmonary disease (COPD) activity are provided. Methods of classifying the (COPD) status of a subject are provided. Systems for expression-based classification of COPD disease status are provided. Methods of treating COPD are also provided, among other things.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THE BRITISH COLUMBIA CANCER AGENCY BRANCH600 WEST 10TH AVENUE VANCOUVER V5Z 4E6

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lam, Stephen Vancouver, CA 127 2094
Lenberg, Marc Brookline, US 2 4
Spira, Avrum Newton, US 33 222
Steiling, Katrina Boston, US 3 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 13, 2024
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 13, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00